Johnson Johnson Stock Earnings Per Share
| JNJ Stock | EUR 148.70 1.76 1.17% |
Johnson Johnson fundamentals help investors to digest information that contributes to Johnson Johnson's financial success or failures. It also enables traders to predict the movement of Johnson Stock. The fundamental analysis module provides a way to measure Johnson Johnson's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Johnson Johnson stock.
Johnson |
Johnson Johnson Company Earnings Per Share Analysis
Johnson Johnson's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Johnson Johnson Earnings Per Share | 6.34 X |
Most of Johnson Johnson's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Johnson Johnson has an Earnings Per Share of 6.34 times. This is 24.25% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The earnings per share for all Germany stocks is 103.21% lower than that of the firm.
Johnson Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Johnson Johnson's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Johnson Johnson could also be used in its relative valuation, which is a method of valuing Johnson Johnson by comparing valuation metrics of similar companies.Johnson Johnson is rated second overall in earnings per share category among its peers.
Johnson Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0871 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 443.95 B | |||
| Shares Outstanding | 2.6 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 71.60 % | |||
| Price To Earning | 29.33 X | |||
| Price To Book | 6.28 X | |||
| Price To Sales | 4.52 X | |||
| Revenue | 94.94 B | |||
| Gross Profit | 63.95 B | |||
| EBITDA | 28.97 B | |||
| Net Income | 17.94 B | |||
| Cash And Equivalents | 25.31 B | |||
| Cash Per Share | 9.61 X | |||
| Total Debt | 26.89 B | |||
| Debt To Equity | 0.48 % | |||
| Current Ratio | 1.39 X | |||
| Book Value Per Share | 29.39 X | |||
| Cash Flow From Operations | 21.19 B | |||
| Earnings Per Share | 6.34 X | |||
| Price To Earnings To Growth | 3.87 X | |||
| Number Of Employees | 152.7 K | |||
| Beta | 0.54 | |||
| Market Capitalization | 372.67 B | |||
| Total Asset | 187.38 B | |||
| Z Score | 7.8 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.57 % | |||
| Net Asset | 187.38 B | |||
| Last Dividend Paid | 4.45 |
About Johnson Johnson Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Johnson Johnson's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Johnson using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Johnson based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.